Jian-Chun Cai
Overview
Explore the profile of Jian-Chun Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu S, Wang Z, Ding Z, Zhang S, Yuan S, Yan F, et al.
Int J Surg
. 2024 Mar;
110(3):1402-1410.
PMID: 38484259
Background: Natural orifice specimen extraction surgery (NOSES) is currently widely used in left-sided colorectal cancer. Some clinical comparative studies have been conducted, providing evidence of its safety and oncological benefits....
2.
Lin J, Tang Y, Zheng H, Ye K, Cai J, Cai L, et al.
Nat Commun
. 2024 Jan;
15(1):41.
PMID: 38167806
Prospective evidence regarding the combination of programmed cell death (PD)-1 and angiogenesis inhibitors in treating locally advanced gastric cancer (LAGC) is limited. In this multicenter, randomized, phase 2 trial (NCT04195828),...
3.
Su C, Yu R, Hong X, Zhang P, Guo Y, Cai J, et al.
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37629071
According to the World Health Organization (WHO), gastric cancer (GC) is the fourth leading cause of tumor-related mortality globally and one of the most prevalent malignant tumors. To better understand...
4.
Zhang L, Zhuo H, Hou J, Zhou Y, Cheng J, Cai J
World J Gastrointest Oncol
. 2022 Nov;
14(11):2097-2107.
PMID: 36438703
Background: Proteomic signatures of Ming's infiltrative gastric cancer (IGC) remain unknown. Aim: To elucidate the molecular characteristics of IGC at the proteomics level. Methods: Twelve pairs of IGC and adjacent...
5.
Su C, Lin Z, Cui Y, Cai J, Hou J
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230637
Backgrounds: Colorectal cancer is the third most prevalent cancer worldwide. A right-sided colon cancer patient typically has a worse prognosis than one who has a left-sided colon cancer. There is...
6.
Xu S, Ding Z, Zhang S, Yuan S, Yan F, Wang Z, et al.
Surg Endosc
. 2022 Jul;
37(1):749-758.
PMID: 35906459
Background: The role of laparoscopic-assisted natural orifice specimen extraction (LA-NOSE) colectomy in the treatment of left-sided colon cancer has not been well defined, and there remains confusion about how to...
7.
Xu S, Cai J
J Surg Res
. 2021 Oct;
270:31-38.
PMID: 34628161
Background: Laparoscopic-assisted natural orifice specimen extraction (LA-NOSE) gastrectomy effectively avoids the need for an abdominal incision, unlike conventional laparoscopic gastrectomy. In this study, we documented our experience with LA-NOSE gastrectomy...
8.
Lin J, Xu Y, Lin W, Xue F, Ye J, Zang W, et al.
JAMA Netw Open
. 2021 Jul;
4(7):e2116240.
PMID: 34241629
Importance: Apatinib is a novel treatment option for chemotherapy-refractory advanced gastric cancer (GC), but it has not been evaluated in patients with locally advanced GC. Objective: To investigate the effectiveness...
9.
Guan X, Liu Z, Parvaiz A, Longo A, Saklani A, Shafik A, et al.
Gastroenterol Rep (Oxf)
. 2020 Feb;
8(1):5-10.
PMID: 32104581
At present, natural orifice specimen extraction surgery (NOSES) has attracted more and more attention worldwide, because of its great advantages including minimal cutaneous trauma and post-operative pain, fast post-operative recovery,...
10.
International consensus on natural orifice specimen extraction surgery (NOSES) for colorectal cancer
Guan X, Liu Z, Longo A, Cai J, Chen W, Chen L, et al.
Gastroenterol Rep (Oxf)
. 2019 Feb;
7(1):24-31.
PMID: 30792863
In recent years, natural orifice specimen extraction surgery (NOSES) in the treatment of colorectal cancer has attracted widespread attention. The potential benefits of NOSES including reduction in postoperative pain and...